178 related articles for article (PubMed ID: 19384297)
1. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients.
Barker CL; Routledge JA; Farnell DJ; Swindell R; Davidson SE
Br J Cancer; 2009 May; 100(10):1558-65. PubMed ID: 19384297
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
3. A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy.
Olopade FA; Norman A; Blake P; Dearnaley DP; Harrington KJ; Khoo V; Tait D; Hackett C; Andreyev HJ
Br J Cancer; 2005 May; 92(9):1663-70. PubMed ID: 15856043
[TBL] [Abstract][Full Text] [Related]
4. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study.
Yucel B; Akkaş EA; Okur Y; Eren AA; Eren MF; Karapinar H; Babacan NA; Kiliçkap S
Support Care Cancer; 2014 Sep; 22(9):2479-87. PubMed ID: 24728584
[TBL] [Abstract][Full Text] [Related]
5. Quality of life outcomes in patients with anal cancer after combined radiochemotherapy.
Welzel G; Hägele V; Wenz F; Mai SK
Strahlenther Onkol; 2011 Mar; 187(3):175-82. PubMed ID: 21347639
[TBL] [Abstract][Full Text] [Related]
6. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
[TBL] [Abstract][Full Text] [Related]
7. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?
Tribius S; Reemts E; Prosch C; Raguse M; Petersen C; Kruell A; Singer S; Bergelt C
Oral Oncol; 2012 Sep; 48(9):898-904. PubMed ID: 22502815
[TBL] [Abstract][Full Text] [Related]
8. Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer.
Barraclough LH; Routledge JA; Farnell DJ; Burns MP; Swindell R; Livsey JE; Davidson SE
Radiother Oncol; 2012 Jun; 103(3):327-32. PubMed ID: 22633812
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer.
Goineau A; Marchand V; Rigaud J; Bourdin S; Rio E; Campion L; Bonnaud-Antignac A; Mahé MA; Supiot S
Radiat Oncol; 2013 Mar; 8():53. PubMed ID: 23510499
[TBL] [Abstract][Full Text] [Related]
11. Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.
Schmidt ME; Chang-Claude J; Vrieling A; Heinz J; Flesch-Janys D; Steindorf K
J Cancer Surviv; 2012 Mar; 6(1):11-9. PubMed ID: 22160661
[TBL] [Abstract][Full Text] [Related]
12. SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment.
Rucinska M; Kieszkowska-Grudny A; Nawrocki S
Strahlenther Onkol; 2016 Jul; 192(7):449-57. PubMed ID: 27221312
[TBL] [Abstract][Full Text] [Related]
13. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
Lilleby W; Fosså SD; Waehre HR; Olsen DR
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy.
Akthar AS; Liao C; Eggener SE; Liauw SL
Eur Urol; 2019 Nov; 76(5):686-692. PubMed ID: 31113644
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
16. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy.
Allal AS; Sprangers MA; Laurencet F; Reymond MA; Kurtz JM
Br J Cancer; 1999 Jul; 80(10):1588-94. PubMed ID: 10408404
[TBL] [Abstract][Full Text] [Related]
17. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy.
Ravasco P; Monteiro-Grillo I; Camilo M
Am J Clin Nutr; 2012 Dec; 96(6):1346-53. PubMed ID: 23134880
[TBL] [Abstract][Full Text] [Related]
18. Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.
Kupelian PA; Reddy CA; Klein EA; Willoughby TR
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):988-93. PubMed ID: 11704322
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers.
Kuku S; Fragkos C; McCormack M; Forbes A
Br J Cancer; 2013 Sep; 109(6):1504-12. PubMed ID: 24002603
[TBL] [Abstract][Full Text] [Related]
20. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
